Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 8
1964 16
1965 7
1966 7
1967 14
1968 21
1969 39
1970 37
1971 45
1972 47
1973 28
1974 56
1975 34
1976 40
1977 49
1978 47
1979 57
1980 42
1981 39
1982 44
1983 58
1984 69
1985 76
1986 95
1987 116
1988 134
1989 155
1990 225
1991 274
1992 297
1993 315
1994 388
1995 314
1996 374
1997 396
1998 398
1999 364
2000 403
2001 427
2002 442
2003 505
2004 416
2005 439
2006 488
2007 510
2008 474
2009 509
2010 504
2011 547
2012 521
2013 596
2014 594
2015 686
2016 617
2017 606
2018 541
2019 562
2020 590
2021 571
2022 531
2023 509
2024 126

Text availability

Article attribute

Article type

Publication date

Search Results

16,300 results

Results by year

Filters applied: . Clear all
Page 1
Non-Hodgkin lymphoma.
Shankland KR, Armitage JO, Hancock BW. Shankland KR, et al. Lancet. 2012 Sep 1;380(9844):848-57. doi: 10.1016/S0140-6736(12)60605-9. Epub 2012 Jul 25. Lancet. 2012. PMID: 22835603 Review.
Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remaining 90% are referred to as non-Hodgkin lymphoma. Non-Hodgkin lymphomas have a wide range of histological ap …
Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remainin …
PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S. Zanoni L, et al. Semin Nucl Med. 2023 May;53(3):320-351. doi: 10.1053/j.semnuclmed.2022.11.001. Epub 2022 Dec 14. Semin Nucl Med. 2023. PMID: 36522191 Review.
Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative disorders characterized by different clinical courses, varying from indolent to highly aggressive. (18)F-FDG-PET/CT is the current state-of-the-art diagnostic imaging, for the staging, res
Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative disorders characterized by different clinical co
Non-Hodgkin lymphoma.
Bowzyk Al-Naeeb A, Ajithkumar T, Behan S, Hodson DJ. Bowzyk Al-Naeeb A, et al. BMJ. 2018 Aug 22;362:k3204. doi: 10.1136/bmj.k3204. BMJ. 2018. PMID: 30135071 Review. No abstract available.
Non-Hodgkin Lymphoma: Diagnosis and Treatment.
Ansell SM. Ansell SM. Mayo Clin Proc. 2015 Aug;90(8):1152-63. doi: 10.1016/j.mayocp.2015.04.025. Mayo Clin Proc. 2015. PMID: 26250731 Review.
Non-Hodgkin lymphomas are lymphoid malignant neoplasms with diverse biological and clinical behavior. ...Most patients respond well to treatment, but relapses are frequent and additional therapies including stem cell transplant are often needed. Because many subtype
Non-Hodgkin lymphomas are lymphoid malignant neoplasms with diverse biological and clinical behavior. ...Most patients respond
Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives.
Cairo MS, Beishuizen A. Cairo MS, et al. Br J Haematol. 2019 Jun;185(6):1021-1042. doi: 10.1111/bjh.15764. Epub 2019 Feb 6. Br J Haematol. 2019. PMID: 30729513 Free PMC article. Review.
The 6th International Symposium on Childhood, Adolescent and Young Adult (CAYA) Non-Hodgkin Lymphoma (NHL) was held in Rotterdam, Netherlands, 26-29 September, 2018. This summary manuscript is a perspective on the presentations from the plenary scientific ses …
The 6th International Symposium on Childhood, Adolescent and Young Adult (CAYA) Non-Hodgkin Lymphoma (NHL) was held in …
Primary CNS Lymphoma.
Grommes C, DeAngelis LM. Grommes C, et al. J Clin Oncol. 2017 Jul 20;35(21):2410-2418. doi: 10.1200/JCO.2017.72.7602. Epub 2017 Jun 22. J Clin Oncol. 2017. PMID: 28640701 Free PMC article. Review.
Primary CNS lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma that is typically confined to the brain, eyes, and cerebrospinal fluid without evidence of systemic spread. ...
Primary CNS lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma that is typically confined to the …
Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.
McCarten KM, Nadel HR, Shulkin BL, Cho SY. McCarten KM, et al. Pediatr Radiol. 2019 Oct;49(11):1545-1564. doi: 10.1007/s00247-019-04529-8. Epub 2019 Oct 16. Pediatr Radiol. 2019. PMID: 31620854 Review.
Hodgkin lymphoma and non-Hodgkin lymphoma are common malignancies in children and are now highly treatable. ...Non-Hodgkin lymphoma includes more organ involvement such as renal, ovary, central nervous system and skin. ...
Hodgkin lymphoma and non-Hodgkin lymphoma are common malignancies in children and are now highly treatabl
Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma.
Nastoupil LJ, Bartlett NL. Nastoupil LJ, et al. J Clin Oncol. 2023 Feb 1;41(4):903-913. doi: 10.1200/JCO.22.01848. Epub 2022 Dec 12. J Clin Oncol. 2023. PMID: 36508700 Review.
Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a heterogenous group of morphologically, genetically, and clinically distinct diseases. ...
Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a heterogenous group o …
Non-Hodgkin Lymphoma Metabolism.
Kirsch BJ, Chang SJ, Le A. Kirsch BJ, et al. Adv Exp Med Biol. 2018;1063:95-106. doi: 10.1007/978-3-319-77736-8_7. Adv Exp Med Biol. 2018. PMID: 29946778 Review.
Non-Hodgkin lymphomas (NHLs) are a heterogeneous group of lymphoid neoplasms with differing biological characteristics. ...The treatment of NHLs depends on neoplastic histology and the stage of the tumor, which will indicate whether radiotherapy, chemotherapy, or a
Non-Hodgkin lymphomas (NHLs) are a heterogeneous group of lymphoid neoplasms with differing biological characteristics. ...The
Non-Hodgkin lymphoma.
Evans LS, Hancock BW. Evans LS, et al. Lancet. 2003 Jul 12;362(9378):139-46. doi: 10.1016/S0140-6736(03)13868-8. Lancet. 2003. PMID: 12867117 Review.
Non-Hodgkin lymphoma is a non-specific term that includes several lymphoproliferative malignant diseases with different clinical and histological appearances. ...Developments in cytotoxic chemotherapy have led to good long-term survival prospects for a
Non-Hodgkin lymphoma is a non-specific term that includes several lymphoproliferative malignant diseases with di
16,300 results
You have reached the last available page of results. Please see the User Guide for more information.